PsychLight Sensor to Enable Discovery of New Psychiatric Drugs
by Andy Fell April 28, 2021 A genetically encoded fluorescent sensor to detect hallucinogenic compounds has been developed by researchers at the University of California, Davis. Named psychLight, the sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse. The work is published April 28 in the journal Cell. Compounds related to psychedelic drugs such as LSD and dimethyltryptamine (DMT) show great promise for treating disorders such as depression, post-traumatic stress disorder and substance use disorder. These drugs are ca...
Source: ucdavis.edu